INTRODUCTION
Bacillus anthracis is a sporulating gram-positive bacterium and the causative agent of the zoonotic disease anthrax. Present ubiquitously in soils worldwide, B. anthracis is dissimilar to other organisms within the Bacillus genus in that it produces the lethal anthrax toxin. While linked to several bioterrorism attacks and highly fatal to humans, the bacterium predominately affects feeding ruminants through the inhalation of endospores. 1 Under environmental stresses such as nutrient deprivation, vegetative cells divide to metabolically inactive spores that can remain dormant for prolonged periods of time. 2, 3 Once these are internalised, the spores revert and subsequently produce the anthrax toxin which ultimately leads to death. After a period of time, spore production once again proceeds and improper handling of the infected carcases can result in the zoonotic transfer to people. Indeed, the primary mode of human infection is through the ingestion, inhalation or direct contact of spores to skin abrasions originating from contaminated animal sources. 4 Human infection of anthrax can be divided into three forms: cutaneous (contact of spores to skin lesions), gastrointestinal (ingestion) and pulmonary (inhalation of spores). Cutaneous anthrax, the most common form of the disease, is characterised primarily through the formation of visible black eschars. 5 Although the most prevalent, it is also the most easily treated and if discovered early is rarely fatal. 6 Gastrointestinal anthrax is caused through the consumption of contaminated meat and occurrence is rare in developed nations and more frequent in countries without stringent quality control programs. Symptoms include vomiting of blood, severe diarrhoea and lesions from the oral cavity to the cecum. 7 Pulmonary anthrax is the most deadly form of the disease and is historically associated with bioterrorism, although infection can also occur through industrial contact (wool mills, tanneries etc). Symptoms include respiratory failure, multi-organ failure and shock, and if left untreated have up to a 90% mortality rate. 8 Current antibiotic strategies include the combination of both intravenous and oral antibiotics, including ciprofloxacin, doxycycline and penicillin G. 9 While considered the most effective method of treatment, there is always an inherent risk that the bacterium may develop an antibiotic resistance to one or more of this antibiotics.Indeed, strains with naturally conferred resistances to penicillins and cephalosporins have been previously isolated. 10 Furthermore, a tailored, multi-drug resistant strain of B.anthracis may be used in bioterrorism which would decrease available treatment options. Therefore the synthesis of new drugs or discovery of antibacterial compounds in pre-existing natural assets is vital to ensure viable treatment options are available.The antimicrobial properties of medicinal plants have long been recognised by many cultures and the identification of the active compounds offers potential in the development of new anti-B. anthracis agents.Thus the investigation of natural assets provides an opportunity to discover compounds effective in the treatment of anthrax. The genus Terminalia encompasses approximately 200-250 species of flowering trees and has an extensive association with usage in traditional medicinal systems. 11 The antibacterial activity of this genus has been extensively reported. Extracts prepared from the fruit of the Australian species Terminalia ferdinandiana (Kakadu plum) have potent growth inhibitory activity against an extensive panel of pathogenic bacteria including bacteria associated diarrhoea and dysentery 12 as well as the bacterial triggers of rheumatoid arthritis (Proteus mirabilis) 13 and multiple sclerosis (Acinitobacterbaylyi and Pseudomonas aeruginosa).
14 Leaf extracts from the same species have also been shown to inhibit growth of the same bacteria, as well as a microbial trigger of ankylosing spondylitis (Klebsiella pneumoniae). 15 19, 20 Terminalia chebula has traditional uses in Ayurveda for the treatment of numerous diseases and conditions 21 and has potent antibacterial activity. 19 Similarly, Terminalia alata, Terminalia bellirica and Terminalia catappa have broad spectrum antibacterial activity. 20 However, despite the wealth of antibacterial studies for Terminalia spp., there is a lack of studies screening Terminalia spp. for the ability to inhibit B. anthracis growth. Indeed, a literature search only found a single study which reported B. anthracis growth inhibitory activity for T. stenostachya and T. spinosa 16 and a further study which reported lack of inhibitory activity for Terminalia glaucescens. 22 Our study was undertaken to examine the ability of selected Asian Terminalia spp. with extensive usage in Ayurvedic medicine for the ability to inhibit B. anthracis growth.
MATERIALS AND METHODS

Plant source and extraction
The Terminalia chebula, Terminalia catappa and Terminalia arjuna plant materials used in this study were a gift from Dr Paran Rayan, Griffith University. Voucher samples of all plant specimens have been stored at the School of Natural Sciences, Griffith University, Brisbane Australia. The plant materials were thoroughly desiccated in a Sunbeam food dehydrator and the dried materials stored at -30 o C until use. Prior to usage, the materials were thawed and ground into a coarse powder. Individual 1 g quantities of the material were weighed into separate tubes and 50 mL of methanol, deionised water, chloroform, hexane or ethyl acetate were added. All solvents were obtained from Ajax and were AR grade. The ground plant materials were individually extracted in each solvent for 24 hours at 4 o C with gentle shaking. The extracts were then filtered through filter paper (Whatman No. 54) under vacuum, followed by drying by rotary evaporation in an Eppendorf concentrator 5301.
The resultant extracts were weighed and redissolved in 10 mL deionised water (containing 1% DMSO).
Qualitative phytochemical studies
Phytochemical analysis of the extracts for the presence of tannins, saponins, triterpenoids, phenolic compounds, flavonoids, phytosteroids, cardiac glycosides, anthraquinones, and alkaloids was conducted as previously described.
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Antibacterial screening
Environmental Bacillus anthracis strain An environmental strain of Bacillus anthracis was isolated and used in these studies. The bacterium was originally isolated from a water sample taken from Paralana hot springs (30°17'49"S, 139°44'15"E), South Australia. Isolation was achieved through successive culturing steps using a modified peptone/yeast extract (PYE) agar as previously described. 31 The GenBank accession number for the 16S rRNA gene sequence for the isolate is KR003287.
Evaluation of antimicrobial activity
The antimicrobial activity of all plant extracts was assessed using a modified disc diffusion assay as previously described. [32] [33] [34] Briefly, 100 µL of B. anthracis was grown in 10 mL of fresh PYE media until a cell count of approximately 10 8 cells/mL was achieved. An amount of 100 µL of bacterial suspension was spread onto nutrient agar plates. The extracts were tested for antibacterial activity using 5 mm sterilised filter paper discs. Discs were infused with 10 µL of the text sample, allowed to dry and placed onto inoculated plates. The plates were allowed to stand at 4 o C for 2 hours before incubation at 30 o C for 24 hours. The diameters of the inhibition zones were measured in millimetres. All measurements were rounded to the closest whole millimetre. Each assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of chloramphenicol (10 µg) and penicillin-G (2 µg) were obtained from Oxoid Ltd. and served as positive controls for antibacterial activity. Filter discs infused with 10 µL of sterilised water were used as a negative control.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentration (MIC) of each extract was determined as previously described. 35, 36 Briefly, the plant extracts were diluted Triterpenoids, flavonoids, tannins, gallic and ellagic acid, sitosterol,proanthocyanidins 11, 26, 27 in deionised water and tested across a range of concentrations. Discs were infused with 10 µL of the test dilutions, allowed to dry and placed onto inoculated plates. The assay was achieved as outlined above and graphs of the zone of inhibition versus concentration were plotted for each extract. Linear regression was used to calculate the MIC values of each extract.
Toxicity screening
Reference toxin for toxicity screening Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared as a 4 mg/mLsolution in distilled water and was serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay.
Artemia franciscana nauplii toxicity screening Toxicity was tested using an adapted Artemia franciscana nauplii lethality assay as previously described. [37] [38] [39] Briefly, 400 µL of seawater containing approximately 43 (mean 43.2, n = 155, SD 14.5) A. franciscana nauplii were added to wells of a 48 well plate and immediately used for bioassay. A volume of 400 µL of diluted plant extracts or the reference toxin were transferred to the wells and incubated at 25 ± 1 o C under artificial light (1000 Lux). A negative control (400 µL seawater) was run in triplicate for each plate. All treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead counted. The nauplii were considered dead if no movement of the appendages was detected within 10 seconds. Following 24 h exposure, all nauplii were sacrificed and counted to determine the total % mortality per well. The LC 50 with 95% confidence limits for each treatment was determined using probit analysis.
Statistical analysis
Data are expressed as the mean ± SEM of at least three independent experiments.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
Extraction of 1 g of the various dried plant materials with the solvents yielded dried plant extracts ranging from 22 mg (T. arjuna leaf ethyl acetate extract) to 634 mg (T. chebula methanolic fruit extract) ( Table 2 ). In general, T. chebula fruit extracts gave higher yields of dried extracted material compared with the corresponding extracts of the other Terminalia spp. The exceptions were the low polarity (chloroform and hexane) T. catappa fruit extracts, both of which had substantially higher amounts of extracted material than the corresponding T. chebula and T. arjuna extracts. Indeed, the T. catappa chloroform and hexane extracts had greater masses of extracted material than the aqueous and methanolic extracts. The dried extracts were resuspended in 10 mL of deionised water (containing 1% DMSO) resulting in the extract concentrations shown in Table 2 . Qualitative phytochemical studies showed that the methanolic and aqueous extracts of all species generally had a wide range of phytochemicals (Table 2 ). Both solvents generally extracted high levels of phenolics (particularly water soluble phenolics) for all plant materials. The methanolic and aqueous extracts generally extracted high levels of flavonoids and tannins and moderate to high levels of saponins. The ethyl acetate extracts had similar phytochemical profiles as the methanolic and aqueous extracts, although most classes of compounds were present at lower abundance. In contrast, the chloroform and hexane extracts of most of the Terminalia plant specimens generally only had low to moderate levels of phenolics, flavonoids and tannins. The chloroform and hexane extracts were generally devoid of detectable levels of the other classes of phytochemicals. 
+++indicates a large response; ++ indicates a moderate response; + indicates a minor response; -indicates no response in the assay. W = aqueous extract; M = methanolic extract; C = chloroform extract; H = hexane extract; E = ethyl acetate extract. 50 value could not be obtained as the mortality did not reach 50% for any dose tested. W = aqueous extract; M = methanolic extract; C = chloroform extract; H = hexane extract; E = ethyl acetate extract. 
Antimicrobial activity
To determine the ability of the crude plant extracts to inhibit the growth of B. antharcis, aliquots (10 µL) of each extract were screened using a disc diffusion assay. The bacterial growth was inhibited by 9 of the 15 extracts screened (60 %) (Figure 1 ). The T. Chebula aqueous and methanolic fruit extracts were the most potent inhibitor of B. antharcis growth (as judged by zone of inhibition), with inhibition zones of 20.7 ± 0.7 mm and 20.0 ± 0 mm respectively.This compares favourably with the penicillin and ampicillin controls, which had zones of inhibition of 8.3 ± 0.6 and 9.6 ± 0.6 mm respectively. The T. chebula chloroform extracts also displayed good growth inhibitory activity (9.3 ± 0.3 mm), whilst the T. chebula hexane and ethyl acetate extracts were devoid of growth inhibitory activity. The T. catappa methanolic, chloroform and hexane extracts, as well as the T. arjuna methanolic, chloroform and hexane extracts also displayed moderate inhibitory activity. All other extracts were devoid of B. antharcis growth inhibitory activity. The antimicrobial efficacy was further quantified by determining the MIC values ( Table 3 ). The methanolic T. chebula fruit extract was particularly effective at inhibiting microbial growth, with MIC values against B. anthracis of 166 µg/mL (<2 µg impregnated in the disc). The aqueous T. chebula fruit extract, as well as the T. catappa and T. arjuna methanolic extracts were also displayed good growth inhibition with MIC's generally <2500 µg/mL (<25 µg impregnated in the disc). All other plant extracts were either inactive or of only low inhibitory activity.
Quantification of toxicity
All extracts were initially screened at 2000 µg/mL in the assay (Figure 2 ). For comparison, the reference toxin potassium dichromate (1000 µg/mL) was also tested in the bioassay. The potassium dichromate reference toxin was rapid in its onset of mortality, inducing nauplii death within the first 3 hours of exposure and 100% mortality was evident following 4-5 hours (results not shown). The aqueous and methanolic extracts of all Terminalia spp. were toxic in the Artemia nauplii bioassay, with> 50% mortality rates at 24 h. The mortality for all other extracts was not significantly different to the mortality seen for the seawater control.
To further quantify the effect of toxin concentration on the induction of mortality, the extracts were serially diluted in artificial seawater to test across a range of concentrations in the Artemia nauplii bioassay. 19, 20 T. chebula also has a tradition of use in Ayurveda for the treatment of numerous diseases and conditions. 21 T. chebula has also been reported to display potent antibacterial activity against a microbial panel. 19 Similarly, T. alata, T. bellirica and T. catappa have also been reported to have broad spectrum antibacterial activity. 20 Interestingly, whilst B. anthracis was not tested in any of the previous studies, several reports indicate strong growth inhibition of the related bacterial species Bacillus subtilis. T. catappa was a particularly potent growth inhibitor, with an MIC of 5 µg/mL reported. 41 A different study reported growth inhibition of 2 Bacillus spp. including B. subtilis at doses as low as 100 µg/mL. 42 Similarly, inhibition of B. subtilis growth was reported for T. arjuna at 1000 µg/mL. 43 However, that study did not report MIC values, making it difficult to compare efficacy between the extracts. B. subtilis is closely related to B. anthracis with approximately 95% 16S rRNA sequence homology. 44 Indeed, under current taxonomic standards, bacteria with >97% 16S rRNA sequence homology are generally classified as a single species. It is therefore perhaps not surprising that the Indian Terminalia spp. extracts screened in our study displayed growth inhibitory activity towards B. anthracis. Whilst an examination of the phytochemistry of the Terminalia spp. examined in our study was beyond the scope of our study, a commonality of this genus is their relatively high levels of a number of tannin components including exifone (4-galloylpyrogallol), ellagic acid dehydrate, trimethylellagic acid, chebulic acid, corilagen, castalagin and chebulagic acid. 11, [13] [14] [15] Gallotannin shave been reported to inhibit the growth of a broad spectrum of bacterial species 45 through a variety of mechanisms including binding cell surface molecules including lipotoichoic acid and proline-rich cell surface proteins 46, 47 and by inhibiting glucosyltransferase enzymes. 48 Elligitannins are also highly potent inhibitors of bacterial growth, with MIC values as low as 62.5 µg/ml. 45 Ellagitannins have also been reported to function via several antibiotic mechanisms including interaction with cytoplasmic oxidoreductases and by disrupting bacterial cell walls. 45, 47 It is likely that other phytochemical classes also contribute to the growth inhibitory properties of these extracts. Our qualitative phytochemical screening studies indicate that polyphenolics, flavonoids, saponins, and terpenes were present in the Terminalia spp. extracts. Terpenoids have been previously reported to have potent broad spectrum antibacterial activity 49 and therefore may contribute to the inhibitory activity against B. anthracis. Many studies have also reported potent antibacterial activities for a wide variety of flavonoids. 50 Further phytochemical evaluation studies and bioactivity driven isolation of active components is required to further evaluate the mechanism of B. anthracis growth inhibition.
The findings reported here demonstrate that all of the Indian Terminalia extracts tested in our study were nontoxic towards Artemia franciscananauplii, with LC 50 values substantially>1000 µg/mL. Extracts with LC 50 values>1000 µg/mL towards Artemia nauplii are defined as being nontoxic. 40 Whilst our preliminary toxicity studies indicate that these extracts may be safe for use as B. anthracis growth inhibitors, studies using human cell lines are required to further evaluate the safety of these extracts. Furthermore, whilst the results of our study are promising, it must be noted that the growth inhibitory studies screened against vegetative cells. As Bacillus spp. are spore formers, further studies are required to determine whether extracts with B. anthracis growth inhibitory activity also affect bacterial growth from the spores.
CONCLUSION
The results of this study demonstrate the potential of various Indian Terminalia spp. in the growth inhibition of B. anthracis. Further investigations aimed at the purification of the bioactive components are needed to assess the mechanisms of action of these agents.
